1.
Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma. Radiol Oncol. 2025;59(3):403-411. Accessed September 20, 2026. https://radioloncol.com/index.php/ro/article/view/4680